New pathway cuts red tape and brings predictability to Medicare coverage for Breakthrough Devices.
Companies that embed Market Access early in innovation are the ones best positioned to navigate the changing global landscape.
The next phase of digital mental health adoption depends less on innovation and more on how the industry uses real-world evidence, builds reimbursement frameworks, and applies regulatory precedent to accelerate scale.
89% of KLAS-surveyed customers use Xsolis’ AI technology to minimize preventable denials.
Many medical device companies want to go to Japan since it is the third-largest market in the world. Oftentimes, device companies want to register their devices quickly in Japan to be on the market and are not focused enough on the initial medical device reimbursement they will get. This can lead to an unprofitable business if the Japanese reimbursement price is not higher than the sales price in Japan. Are there strategies to increase reimbursement?
Medical Devices must be fully reimbursable – no out of pocket expenses – in Japan. So, how is reimbursement achieved for your medical device?
careviso Survey Highlights Major Communication Gaps in Healthcare, Impacting Financial Transparency and Patient Experience
Billions of dollars are lost annually in medical billing errors resulting from data entry mistakes, outdated coding practices, and duplicated charges. Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the process of claims processing, diagnostics, eliminating errors, streamlining workflow, and increasing the accuracy of claims submissions. Together with human oversight to ensure precision and safety, AI augments healthcare professionals to improve patient care and outcomes.
In the face of sweeping Medicare changes for 2025, millions of seniors face the challenge of navigating a complex landscape of new options, increased costs, and altered benefits. Innovative technologies are emerging as crucial tools for both patients and healthcare providers, offering detailed cost comparisons, network analyses, and benefit breakdowns.
Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese government has pledged not to allow Japanese device reimbursement to be as high as the US prices.